BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/06/2024

FDA Releases Guidance on Demonstrating Bioequivalence for Poorly Soluble Medications

The FDA has released a final guidance for industry on demonstrating bioequivalence for generic medications that are poorly soluble in water and have limited systemic absorption, a process that can be challenging to study.

Source: Federal Register — Food and Drug AdministrationOpen original release →